Recent Advances in Decellularization and Recellularization for Tissue-Engineered Liver Grafts.

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Transplantation Immunology

Background:

• End-stage liver disease necessitates liver transplantation, but donor organ scarcity is a critical limitation.
• Tissue-engineered liver grafts, utilizing decellularized extracellular matrix and cells, are being explored as an alternative.
• Significant research has focused on optimizing decellularization and recellularization processes.

Purpose of the Study:

• To review recent advances in tissue-engineered liver graft development.
• To summarize key aspects of decellularization and recellularization protocols.
• To highlight progress towards creating transplantable, human-sized liver grafts.

Main Methods:

• Generation of high-quality decellularized liver extracellular matrix (ECM) scaffolds.
• Establishment of quality control criteria for ECM scaffolds.
• Modification of ECM scaffolds to enhance their properties.
• Development and refinement of cell reseeding strategies.

Main Results:

• Progress has been made in generating decellularized liver ECM scaffolds of sufficient quality.
• Effective evaluation criteria for scaffold quality have been developed.
• Matrix modification techniques show promise for improving scaffold performance.
• Various reseeding strategies are being investigated for optimal cell integration.

Conclusions:

• Optimized decellularization and recellularization methods are crucial for successful tissue-engineered liver grafts.
• These advancements are foundational for developing transplantable, human-sized liver grafts.
• The ultimate goal is to provide a viable treatment option for patients with severe liver disease.